SEEING IS RELIEVING
Between computers, tablets, and smartphones, we need help from our glasses more than ever before. All that screen time can be hard on your eyes and may cause digital eye strain. Eyezen® enhanced single vision lenses are more than just ordinary glasses, they provide sharper vision than ordinary single vision lenses and are available to everyone—whether you have a prescription or just want a pair of computer glasses.

Eyezen+ lenses are a more complete solution to modern vision problems than traditional single vision lenses. Eyezen+ lenses are an everyday, enhanced single vision solution for patients suffering from symptoms of digital eye strain.

Eyezen+ lenses also come systematic with the Smart Blue Filter™ to reduce exposure to Harmful Blue Light.

DESIGNED FOR THE WAY YOU SEE THE WORLD
Eyezen enhanced single vision lenses are designed for the way you see the world, reducing strain from viewing digital devices. They perform better than computer glasses and filter Harmful Blue Light, helping to keep your eyes protected and comfortable, even on your most digital days.

DIGITAL EYE STRAIN
Digital eye strain is defined as the physical eye discomfort felt after two or more hours in front of a digital screen. It originates from the overexertion of certain muscles that help your eyes focus.

​Digital devices and usages are increasing the demands on our eyes. Closer and variable reading distances, smaller and more pixelated characters and longer exposure to screen glare are causing tired eyes and potentially exposing our eyes to the longer-term consequences of harmful blue-violet light. As many as three out of four people feel that they suffer from visual fatigue.



HARMFUL BLUE LIGHT
Harmful Blue Light is all around you, due to the increasing use of devices and new lighting technologies inside and sunlight outside. Harmful Blue Light is one of many risk factors such as age, genetics, diet, lifestyle, and occupation, that may contribute to age-related macular degeneration (AMD). AMD is a leading cause of severe vision loss and blindness in adults over the age of 60.